Biotech company eGenesis recently announced its implanted a pig kidney into a second human patient. This animal-to-human organ transplant, or xenotransplant, was made possible through advancements in ...

First-in-human clinical trial will evaluate a novel perfusion system using a genetically engineered porcine liver for critically ill patients with no transplant option To date, four perfusions with ...

eGenesis has gained US Food and Drug Administration (FDA) clearance on an investigational new drug (IND) application for a genetically engineered porcine (pig) liver. The organ is designed for use ...

IND supports Phase 1/2/3 study that will evaluate safety and efficacy at 24 weeks The first patient in the ongoing Multi-Patient Expanded Access study has surpassed seven months kidney function; a ...

CAMBRIDGE, Mass. and IRVINE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- eGenesis, Inc. (“eGenesis”) and Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN ...

EGenesis has announced a research collaboration with Duke University’s school of medicine to help develop its xenotransplantation technology into a cell therapy for diabetes. The project will begin ...

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Conor Hale, and we will feature ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company focused on utilizing genome editing technology to make xenotransplantation a routine and lifesaving medical procedure, today ...

Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started. Last Thursday, surgeons at ...

eGenesis is a developer of human-compatible organs created through its own multiplexed gene editing platform. Church is a co-founder of the company. [eGenesis] eGenesis, a developer of ...

Dr. Barth brings over 25 years of industry experience within the biotech and pharmaceutical sectors leading clinical development of transformational therapies eGenesis, a biotechnology company ...

A medical team performs a conventional kidney transplant in an undated photo, but a bio-engineered kidney soon might be available to help many more people. File Photo by Tareq Salahuddin/UPI April 15 ...